General Information of Drug (ID: DMXQCBU)

Drug Name
Valtorcitabine Drug Info
Synonyms Epcitabine; Torcitabine; LDC-300; NV-02C; L-2-deoxycytidine; Val-L-dC; Beta-L-2`-deoxycytidine; L-dC prodrug, Idenix/Novartis; L-dC, Idenix/Novartis
Indication
Disease Entry ICD 11 Status REF
Hepatitis virus infection 1E50-1E51 Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
9927346
CAS Number
CAS 380886-95-3
TTD Drug ID
DMXQCBU

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Telbivudine DMSWUGE Hepatitis B virus infection 1E51.0 Approved [3]
ATI-2173 DMT5QYJ Hepatitis B 1E51 Phase 2 [4]
NCO-48 DMUSPW5 Hepatitis B virus infection 1E51.0 Phase 1 [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hepatitis B virus Polymerase (HBV P) TTT4SY6 Q67889_HBV Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013710)
2 Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. J Pharm Sci. 2008 Mar;97(3):1109-34.
3 Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92.
4 ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00836-20.
5 Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects